{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:17:40Z","timestamp":1793506660006,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","cell.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Parasitology"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.pt.2016.10.010","type":"journal-article","created":{"date-parts":[[2016,11,16]],"date-time":"2016-11-16T17:31:58Z","timestamp":1479317518000},"page":"194-201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"title":["Sm-p80-Based Schistosomiasis Vaccine: Preparation for Human Clinical Trials"],"prefix":"10.1016","volume":"33","author":[{"given":"Afzal A.","family":"Siddiqui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina Z.","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 2","key":"10.1016\/j.pt.2016.10.010_bib0275","doi-asserted-by":"crossref","first-page":"88","DOI":"10.4269\/ajtmh.2000.62.88","article-title":"The epidemiology of schistosomiasis in Egypt: summary findings in nine governorates","volume":"62","author":"El-Khoby","year":"2000","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.pt.2016.10.010_bib0280","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMra064142","article-title":"Control of neglected tropical diseases","volume":"357","author":"Hotez","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pt.2016.10.010_bib0285","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S1473-3099(06)70521-7","article-title":"Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk","volume":"6","author":"Steinmann","year":"2006","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.pt.2016.10.010_bib0290","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1016\/S0140-6736(13)61949-2","article-title":"Human schistosomiasis","volume":"383","author":"Colley","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.pt.2016.10.010_bib0295","doi-asserted-by":"crossref","first-page":"e2865","DOI":"10.1371\/journal.pntd.0002865","article-title":"The global burden of disease study 2010: interpretation and implications for the neglected tropical diseases","volume":"8","author":"Hotez","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.pt.2016.10.010_bib0300","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0001-706X(03)00029-9","article-title":"Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa","volume":"86","author":"van der Werf","year":"2003","journal-title":"Acta Trop."},{"key":"10.1016\/j.pt.2016.10.010_bib0305","doi-asserted-by":"crossref","first-page":"e2106","DOI":"10.1371\/journal.pntd.0002106","article-title":"Evaluation of the health-related quality of life of children in Schistosoma haematobium-endemic communities in Kenya: a cross-sectional study","volume":"7","author":"Terer","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.pt.2016.10.010_bib0310","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.actatropica.2009.11.012","article-title":"Parasites and poverty: the case of schistosomiasis","volume":"113","author":"King","year":"2010","journal-title":"Acta Trop."},{"key":"10.1016\/j.pt.2016.10.010_bib0315","doi-asserted-by":"crossref","first-page":"e1321","DOI":"10.1371\/journal.pntd.0001321","article-title":"Utility of repeated praziquantel dosing in the treatment of schistosomiasis in high-risk communities in Africa: a systematic review","volume":"5","author":"King","year":"2011","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.pt.2016.10.010_bib0320","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1016\/j.vaccine.2016.03.112","article-title":"Human anthelminthic vaccines: rationale and challenges","volume":"34","author":"Hotez","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.pt.2016.10.010_bib0325","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S2213-2600(15)00543-3","article-title":"A global view of pulmonary hypertension","volume":"4","author":"Hoeper","year":"2016","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.pt.2016.10.010_bib0330","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S1473-3099(10)70099-2","article-title":"Schistosomiasis elimination: lessons from the past guide the future","volume":"10","author":"Gray","year":"2010","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.pt.2016.10.010_bib0335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpara.2009.11.001","article-title":"Unresolved issues in anthelmintic pharmacology for helminthiases of humans","volume":"40","author":"Geary","year":"2010","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.pt.2016.10.010_bib0255","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/QCO.0b013e328359f04a","article-title":"Are new anthelmintics needed to eliminate human helminthiases?","volume":"25","author":"Geary","year":"2012","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.pt.2016.10.010_bib0260","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1017\/S0031182013000231","article-title":"New approaches for understanding mechanisms of drug resistance in schistosomes","volume":"140","author":"Greenberg","year":"2013","journal-title":"Parasitology"},{"key":"10.1016\/j.pt.2016.10.010_bib0340","doi-asserted-by":"crossref","first-page":"e1549","DOI":"10.1371\/journal.pntd.0001549","article-title":"A research agenda for helminth diseases of humans: intervention for control and elimination","volume":"6","author":"Prichard","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.pt.2016.10.010_bib0345","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1371\/journal.pntd.0001582","article-title":"A research agenda for helminth diseases of humans: the problem of helminthiases","volume":"6","author":"Lustigman","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.pt.2016.10.010_bib0350","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1478-4505-9-3","article-title":"Does mass drug administration for the integrated treatment of neglected tropical diseases really work? Assessing evidence for the control of schistosomiasis and soil-transmitted helminths in Uganda","volume":"9","author":"Parker","year":"2011","journal-title":"Health Res. Policy Syst."},{"key":"10.1016\/j.pt.2016.10.010_bib0265","first-page":"53","article-title":"Schistosomiasis: number of people treated worldwide in 2014","volume":"91","year":"2016","journal-title":"Wkly Epidemiol. Rec"},{"key":"10.1016\/j.pt.2016.10.010_bib0355","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S1473-3099(16)00175-4","article-title":"Outbreak of urogenital schistosomiasis in Corsica (France): an epidemiological case study","volume":"16","author":"Boissier","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.pt.2016.10.010_bib0360","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0001-706X(02)00048-7","article-title":"Blueprint for schistosomiasis vaccine development","volume":"82","author":"Bergquist","year":"2002","journal-title":"Acta Trop."},{"key":"10.1016\/j.pt.2016.10.010_bib0365","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1600-065X.2010.00976.x","article-title":"Vaccines to combat the neglected tropical diseases","volume":"239","author":"Bethony","year":"2011","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.pt.2016.10.010_bib0370","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/nrmicro2438","article-title":"Developing vaccines to combat hookworm infection and intestinal schistosomiasis","volume":"8","author":"Hotez","year":"2010","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.pt.2016.10.010_bib0375","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.4161\/hv.7.11.17017","article-title":"Schistosomiasis vaccines","volume":"7","author":"Siddiqui","year":"2011","journal-title":"Hum. Vaccin."},{"key":"10.1016\/j.pt.2016.10.010_bib0380","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/0264-410X(95)00083-D","article-title":"Human schistosomiasis: potential consequences of vaccination","volume":"12","author":"Woolhouse","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.pt.2016.10.010_bib0385","doi-asserted-by":"crossref","first-page":"e0003598","DOI":"10.1371\/journal.pntd.0003598","article-title":"Hepatitis B vaccines and HPV vaccines have been hailed as major public health achievements in preventing cancer \u2013 could a schistosomiasis vaccine be the third?","volume":"9","author":"Hsieh","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.pt.2016.10.010_bib0390","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1586\/14760584.2016.1131127","article-title":"Development of a schistosomiasis vaccine","volume":"15","author":"Molehin","year":"2016","journal-title":"Expert Rev. Vaccines"},{"issue":"Suppl.","key":"10.1016\/j.pt.2016.10.010_bib0395","first-page":"60","article-title":"Prospects of vaccination against schistosomiasis","volume":"76","author":"Bergquist","year":"1990","journal-title":"Scand. J. Infect. Dis."},{"key":"10.1016\/j.pt.2016.10.010_bib0400","doi-asserted-by":"crossref","first-page":"e244","DOI":"10.1371\/journal.pntd.0000244","article-title":"Trick or treat: the role of vaccines in integrated schistosomiasis control","volume":"2","author":"Bergquist","year":"2008","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.pt.2016.10.010_bib0405","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s00436-008-0887-6","article-title":"Experimental vaccines in animal models for schistosomiasis","volume":"102","author":"Siddiqui","year":"2008","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.pt.2016.10.010_bib0410","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.pt.2005.01.001","article-title":"Vaccine-linked chemotherapy: can schistosomiasis control benefit from an integrated approach?","volume":"21","author":"Bergquist","year":"2005","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.pt.2016.10.010_bib0415","doi-asserted-by":"crossref","first-page":"54","DOI":"10.4269\/ajtmh.13-0467","article-title":"Schistosomiasis elimination strategies and potential role of a vaccine in achieving global health goals","volume":"90","author":"Mo","year":"2014","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.pt.2016.10.010_bib0420","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.vaccine.2015.12.032","article-title":"Workshop report: schistosomiasis vaccine clinical development and product characteristics","volume":"17","author":"Mo","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.pt.2016.10.010_bib0425","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13071-016-1369-9","article-title":"Do schistosome vaccine trials in mice have an intrinsic flaw that generates spurious protection data?","volume":"9","author":"Wilson","year":"2016","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.pt.2016.10.010_bib0430","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1365-3024.2005.00764.x","article-title":"Immunity induced by the radiation-attenuated schistosome vaccine","volume":"27","author":"Hewitson","year":"2005","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.pt.2016.10.010_bib0435","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1016\/j.vaccine.2016.03.079","article-title":"Advancing a vaccine to prevent human schistosomiasis","volume":"34","author":"Merrifield","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.pt.2016.10.010_bib0440","doi-asserted-by":"crossref","first-page":"e1704","DOI":"10.1371\/journal.pntd.0001704","article-title":"Safety and immunogenicity of rSh28GST antigen in humans: phase 1 randomized clinical study of a vaccine candidate against urinary schistosomiasis","volume":"6","author":"Riveau","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.pt.2016.10.010_bib0270","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.vaccine.2015.10.027","article-title":"Schistosomiasis vaccine candidate Sm14\/GLA-SE: Phase 1 safety and immunogenicity clinical trial in healthy, male adults","volume":"34","author":"Santini-Oliveira","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.pt.2016.10.010_bib0445","first-page":"404","article-title":"Life span of parasite in schistosomiasis patients","volume":"26","author":"Arnon","year":"1990","journal-title":"Isr. J. Med. Sci."},{"key":"10.1016\/j.pt.2016.10.010_bib0450","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S1471-4922(01)01893-1","article-title":"Schistosome male-female interaction: induction of germ-cell differentiation","volume":"17","author":"Kunz","year":"2001","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.pt.2016.10.010_bib0455","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.4269\/ajtmh.1983.32.1040","article-title":"Survival of Schistosoma mansoni in the human host: estimates from a community-based prospective study in Puerto Rico","volume":"32","author":"Vermund","year":"1983","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.pt.2016.10.010_bib0460","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0925-4439(93)90087-H","article-title":"Characterization of Ca2+-dependent neutral protease (calpain) from human blood flukes, Schistosoma mansoni","volume":"1181","author":"Siddiqui","year":"1993","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.pt.2016.10.010_bib0465","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1007\/s00436-009-1646-z","article-title":"Prime-boost and recombinant protein vaccination strategies using Sm-p80 protects against Schistosoma mansoni infection in the mouse model to levels previously attainable only by the irradiated cercarial vaccine","volume":"105","author":"Ahmad","year":"2009","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.pt.2016.10.010_bib0470","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1016\/j.vaccine.2009.02.096","article-title":"Protective and antifecundity effects of Sm-p80-based DNA vaccine formulation against Schistosoma mansoni in a nonhuman primate model","volume":"27","author":"Ahmad","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.pt.2016.10.010_bib0475","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/infdis\/jir545","article-title":"Preclinical prophylactic efficacy testing of Sm-p80-based vaccine in a nonhuman primate model of Schistosoma mansoni infection and immunoglobulin G and E responses to Sm-p80 in human serum samples from an area where schistosomiasis is endemic","volume":"204","author":"Ahmad","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.pt.2016.10.010_bib0480","first-page":"1296","article-title":"Cross-species protection: Schistosoma mansoni Sm-p80 vaccine confers protection against Schistosoma haematobium in hamsters and baboons","volume":"32","author":"Karmakar","year":"2014","journal-title":"Vaccine 2014"},{"key":"10.1016\/j.pt.2016.10.010_bib0485","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1093\/infdis\/jiu031","article-title":"Use of an Sm-p80-based therapeutic vaccine to kill established adult schistosome parasites in chronically infected baboons","volume":"209","author":"Karmakar","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.pt.2016.10.010_bib0490","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1086\/651147","article-title":"Sm-p80-based DNA vaccine provides baboons with levels of protection against Schistosoma mansoni infection comparable to those achieved by the irradiated cercarial vaccine","volume":"201","author":"Zhang","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.pt.2016.10.010_bib0495","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1007\/s00436-014-3879-8","article-title":"Longevity of Sm-p80-specific antibody responses following vaccination with Sm-p80 vaccine in mice and baboons and transplacental transfer of Sm-p80-specific antibodies in a baboon","volume":"113","author":"Zhang","year":"2014","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.pt.2016.10.010_bib0500","doi-asserted-by":"crossref","first-page":"e1004033","DOI":"10.1371\/journal.ppat.1004033","article-title":"An immunomics approach to schistosome antigen discovery: antibody signatures of naturally resistant and chronically infected individuals from endemic areas","volume":"10","author":"Gaze","year":"2014","journal-title":"PLoS Pathog."}],"container-title":["Trends in Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471492216301933?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471492216301933?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T13:26:27Z","timestamp":1536240387000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471492216301933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S1471492216301933"],"URL":"https:\/\/doi.org\/10.1016\/j.pt.2016.10.010","relation":{},"ISSN":["1471-4922"],"issn-type":[{"value":"1471-4922","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sm-p80-Based Schistosomiasis Vaccine: Preparation for Human Clinical Trials","name":"articletitle","label":"Article Title"},{"value":"Trends in Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pt.2016.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}